comscore Anti-allergy medicine EpiPen recall expands to U.S. | Honolulu Star-Advertiser
Top News

Anti-allergy medicine EpiPen recall expands to U.S.

  • COURTESY U.S. FOOD AND DRUG ADMINISTRATION

    The U.S. Food and Drug Administration says the EpiPen recall covers 13 lots distributed from December 2015 through July 2016.

A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.

The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing.

Mylan didn’t immediately respond to a question about how many devices are affected by the recall. The U.S. Food and Drug Administration says the recall covers 13 lots distributed from December 2015 through July 2016.

The problems could be potentially life-threatening, although Mylan described the incidence of the defects as “extremely rare.”

The EpiPen is used to treat allergic reactions to certain food and bug bites

The products can be replaced at no charge by calling 877-650-3494 or emailing customer.servicemylan.com.

Click here to see our full coverage of the coronavirus outbreak. Submit your coronavirus news tip.

Be the first to know
Get web push notifications from Star-Advertiser when the next breaking story happens — it's FREE! You just need a supported web browser.
Subscribe for this feature
Comments (0)

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines.

Having trouble with comments? Learn more here.

Scroll Up